Published on 4/11/2006 in the Prospect News Biotech Daily.
SkinMedica completes $11.2 million private placement
By Lisa Kerner
Erie, Pa., April 11 - SkinMedica, Inc. said it closed a $11.2 million private placement of its series E-1 preferred stock.
New investor Montagu Newhall Associates led the round, joined by existing investors Domain Associates, Apax Partners, Perseus-Soros Biopharmaceutical Fund, HealthCare Ventures, EuclidSR Partners and Montreux Equity Partners.
Located in Carlsbad, Calif., SkinMedica is a privately held specialty pharmaceutical company marketing prescription and cosmeceutical dermatology products.
| Issuer: | SkinMedica, Inc.
|
| Issue: | Series E-1 preferred stock
|
| Amount: | $11.2 million
|
| Investors: | Montagu Newhall Associates (lead), Domain Associates, Apax Partners, Perseus-Soros Biopharmaceutical Fund, HealthCare Ventures, EuclidSR Partners, Montreux Equity Partners
|
| Announcement date: | April 11
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
